24 resultados para capital nacional
em Repositório Institucional UNESP - Universidade Estadual Paulista "Julio de Mesquita Filho"
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Este artigo pretende mostrar a importância e o papel do Instituto Pasteur de São Paulo (1903-16) no desenvolvimento da ciência microbiológica no Brasil e no surgimento da indústria farmacêutica de capital nacional.
Resumo:
Pós-graduação em Economia - FCLAR
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Pós-graduação em Ciências Sociais - FCLAR
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Pós-graduação em Ciências Sociais - FCLAR
Resumo:
Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999
Resumo:
The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Pós-graduação em Ciências Sociais - FFC
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)